IP Library Granted Patent US 9,572,909
Granted Patent B2
US 9,572,909 · App. 13/394,415 · Granted Feb 21, 2017

Electrospun nerve guides for nerve regeneration designed to modulate nerve architecture

Inventors: David Simpson (Mechanicsville, VA); Gary Bowlin (Mechanicsville, VA); Raymond Colello (Chester, VA); Woon Chow (Glen Allen, VA); Balendu Shekhar Jha (Richmond, VA)
Assignee: Virginia Commonwealth University
A61L27/18A61B17/1128A61F2/02A61L2430/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,572,909
App. No.
13/394,415
Granted
Feb 21, 2017
Kind
B2
Abstract

Nerve guides which are formed from three dimensional (3D) arrays of highly aligned electrospun fibers are provided. The electrospun fibers are oriented parallel to the long axis of the guide, and gaps and elongated spaces between the stacked fiber arrays provide channels for directed axonal growth. In some embodiments, the nerve guides also comprise high precision gradients of beneficial substances such as growth factors, which aid in nerve regeneration and growth along the guide.

Claims (14)

1. A nerve guide, comprising a plurality of electrospun fibers which are seamlessly aligned parallel to a long axis of said nerve guide;

at least one carrier thread comprising one or more therapeutic substances in a step gradient; and

a plurality of open channels aligned parallel to said long axis of said nerve guide, wherein said at least one carrier thread is different from said plurality of electrospun fibers;

wherein said at least one carrier thread comprises a plurality of segments, wherein each segment comprises the one or more therapeutic substances with a concentration that differs from the concentrations of said one or more therapeutic substances in adjacent segments such that a step gradient of concentration is formed.

2. The nerve guide of claim 1 , wherein said one or more therapeutic substances includes at least one growth factor.

3. The nerve guide of claim 1 , further comprising an outer sheath.

4. The nerve guide of claim 1 , wherein the total length of said at least one carrier thread is from 5 mm to 125 mm.

5. The nerve guide of claim 4 , wherein a length of any one of said plurality of segments is from 1 to 10 mm.

6. The nerve guide of claim 1 , wherein said at least one carrier thread further comprises microbeads present in at least one of the plurality of segments, said microbeads containing an agent of interest.

7. The nerve guide of claim 1 , wherein the step gradient is oriented at a non-zero angle to said long axis.

8. The nerve guide of claim 1 , wherein the step gradient is oriented at right angles to said long axis.

9. The nerve guide of claim 1 , wherein said gradient has a higher concentration in a middle segment of the at least one carrier thread as compared to other segments of said at least one carrier thread.

10. The nerve guide of claim 1 , wherein said at least one carrier thread comprises a plasticizing agent.

11. The nerve guide of claim 1 , wherein said at least one carrier thread comprises alginate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2012
From: SIMPSON, DAVID; BOWLIN, GARY; COLELLO, RAYMOND; CHOW, WOON; JHA, BALENDU SHEKHAR
To: VIRGINIA COMMONWEALTH UNIVERSITY
Reel/Frame 028222/0951 →
Continuity (1)
Related Publication 20120221025A1 · Aug 30, 2012